secwatch.observer — SEC 8-K summary
======================================

Issuer:     Phathom Pharmaceuticals, Inc. (PHAT)
CIK:        0001783183
Form:       8-K
Filed at:   2024-05-24T23:59:59+00:00
Accession:  0001193125-24-147017
Event type: other_material
Sentiment:  neutral
Materiality: 0.20
Item codes: 5.07, 8.01
LLM model:  deepseek-v4-flash:cloud@v2

Phathom stockholders elect three Class II directors; ratify E&Y as auditor
--------------------------------------------------------------------------

- Elected Cola (24.1M for), Karbe (25.0M for), Parikh (21.3M for) with 10.8M broker non-votes each.
- Ratified Ernst & Young as independent auditor for fiscal 2024: 37.9M for, 124.6K against, 1.1K abstain.
- New non-employee directors get initial grant of 21,000 RSUs and options to purchase 35,000 shares.
- Annual director equity grant set at 10,500 RSUs and options for 17,500 shares; cash retainers unchanged.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1783183/000119312524147017/0001193125-24-147017-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1783183/000119312524147017/d810940d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-24-147017

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer